PETV Stock Analysis
PE
Uncovered
PetVivo Holdings Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. The company is headquartered in Edina, Minnesota and currently employs 15 full-time employees. The company went IPO on 2012-07-10. The firm's lead product Spryng with OsteoCushion technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The firm is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a body's cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and heparin. The firm has a pipeline, which includes approximately 17 therapeutic devices for both veterinary and human clinical applications.